Pure Global AI
Disease / condition

Ulcerative Colitis clinical trials

Free access to 707 studies10+ countriesUpdated daily108 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
707
Total trials
10+
Countries
10+
Sponsors
108
Recruiting
By phase
N/A290
Phase 2134
Phase 3110
Phase 172
Phase 445
By status
Completed316
Recruiting108
Not yet recruit...96
Unknown65
Terminated63
Top countries
United States of America104
Japan46
China44
Canada18
Israel16
Top sponsors
Pfizer18
Ferring Pharmaceut...15
Bausch Health Amer...12
AbbVie11
Shire11
Recent trials
Latest clinical trials for Ulcerative Colitis
Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis
The Second Hospital of Nanjing... · China
NCT06421818Recruiting
Phase
Phase 2
T Lymphocyte Subsets in Ulcerative Colitis
Assiut University
NCT06352515Not yet recr...
A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants
Mage Biologics · Australia
NCT06363383Recruiting
Phase
Phase 1
Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients
CannaMore Biotechs · Israel
NCT06353828Recruitment ...
Phase
Phase 2
Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
Tanta University
NCT06335160Not yet recr...
Outcomes of Transanal Tran-section and Single-stapled (TTSS) Ileal Pouch-Anal Anastomosis
Istituto Clinico Humanitas · Italy
NCT06331637Not yet recr...
Controlling the Mental Health for a Better Response to Treatment in Patients With Ulcerative Colitis
IRCCS San Raffaele · Italy
NCT06306261Not yet recr...
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Gilead Sciences
NCT06290934Not yet recr...
Phase
Phase 2
A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates
Zydus Lifesciences Limited · India
NCT06398808Recruiting
Phase
Phase 2
A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
Ferring Pharmaceuticals
NCT06260267Not yet recr...
Phase
Phase 1
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Takeda
NCT06254950Not yet recr...
Phase
Phase 2
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis
Assistance Publique - Hôpitaux... · France
NCT06228352Not yet recr...
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
Xijing Hospital · China
NCT06231264Recruiting
Beneficial Effect of Silymarin in Ulcerative Colitis
Tanta University
NCT06213857Not yet recr...
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Genentech, Inc.
NCT06137183Not yet recr...
Phase
Phase 2
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
AnaptysBio, Inc. · United States of America
NCT06127043Recruiting
Phase
Phase 2
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
Assiut University
NCT06143163Not yet recr...
Pilot Study of a New Medical Food in the Management of Ulcerative Colitis
Stanford University · United States of America
NCT06116643Not yet recr...
Phase
Phase 1
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Takeda · United States of America
NCT06095128Not yet recr...
Phase
Phase 4
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
AltruBio Inc. · Canada,United States of America
NCT06109441Not yet recr...
Phase
Phase 2
About this profile

Access comprehensive clinical trial information for Ulcerative Colitis through Pure Global AI's free database. This collection includes 707 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 108 trials are actively recruiting participants.

Research for Ulcerative Colitis is being conducted in United States of America, Japan, China and 7+ other countries. Leading sponsors include Pfizer and Ferring Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 707 clinical trials studying Ulcerative Colitis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Pfizer, Ferring Pharmaceuticals, Bausch Health Americas, Inc., among others.